Recombinant Peptidyl-prolyl cis-trans isomerase D (ppiD)

What is Peptidyl-prolyl cis-trans isomerase D (PPID)?

Peptidyl-prolyl cis-trans isomerase D (PPID) belongs to the cyclophilin-type PPIase family and PPIase D subfamily. It is widely expressed in human tissues and functions primarily by catalyzing the cis-trans isomerization of proline imidic peptide bonds in oligopeptides, which accelerates protein folding processes . The enzyme contains one PPIase cyclophilin-type domain responsible for its catalytic activity and three TPR (tetratricopeptide repeat) domains that mediate protein-protein interactions . PPID is also known to bind the immunosuppressant cyclosporine A, which can inhibit its enzymatic activity .

How is recombinant PPID produced for research purposes?

Recombinant Human PPID is typically produced using an E. coli expression system. The production process involves expressing the target gene encoding Met1-Ala370 with affinity tags for purification purposes, commonly 6His tags at both the N-terminus and C-terminus . The resulting protein has a molecular weight of approximately 43.9 kD and is supplied as a 0.2 μm filtered solution in a buffer containing 20mM phosphate buffer, 150mM NaCl, at pH 7.4 . This standardized production method ensures consistent protein quality and activity for research applications.

What are the optimal storage conditions for recombinant PPID?

For maintaining optimal activity, recombinant PPID should be stored at -20°C, where it remains stable for approximately 6 months after receipt . Researchers should minimize freeze-thaw cycles as repeated freezing and thawing can compromise protein integrity and enzymatic activity . When working with the protein, it's advisable to aliquot the stock solution into smaller volumes before freezing to avoid multiple freeze-thaw cycles of the entire stock. Additionally, when thawing the protein, it should be done gradually on ice to preserve structural integrity.

How does PPID's structure relate to its function in protein folding?

PPID's structure consists of a PPIase cyclophilin-type domain that contains the active site responsible for catalyzing the cis-trans isomerization reaction, and three TPR repeats that facilitate protein-protein interactions with substrate proteins and regulatory molecules . The PPIase domain contains a hydrophobic pocket that accommodates the proline residue of the substrate peptide. The catalytic mechanism involves stabilizing the transition state between cis and trans conformations, thereby lowering the energy barrier for isomerization.

The amino acid sequence of recombinant PPID includes specific regions that contribute to substrate recognition and binding . For instance, the sequence "VFFDVDIGGERVGRIVLELFADIVPKTAENFRALCTGEKGIGHTTGKPLHFKG" contains residues that form part of the catalytic site, while other segments participate in substrate binding and protein-protein interactions. Understanding this structure-function relationship is crucial for designing experiments that target specific aspects of PPID activity.

What is the relationship between PPID and transcriptional regulation?

PPID, like other members of the PPIase family, plays significant roles in gene transcription regulation at multiple levels. PPIases have been found to regulate all phases of the transcription process . They control upstream signaling pathways that regulate gene-specific transcription during development, hormone responses, and reactions to environmental stressors .

One specific mechanism involves interaction with RNA polymerase II C-terminal domain (CTD), influencing its phosphorylation state and consequently affecting transcription initiation, elongation, or termination . Additionally, PPIases can modify chromatin accessibility through interactions with histone-modifying enzymes, thus indirectly regulating gene expression. This transcriptional regulatory function places PPID at a critical junction in cellular signaling networks and gene expression control.

How does PPID's enzymatic activity compare with other cyclophilins?

PPID shows both similarities and differences in enzymatic parameters compared to other cyclophilins. For context, Cyclophilin J (CYPJ), another member of the cyclophilin family, has a catalytic efficiency (kcat/KM) of 9.5×10^4 s^-1 M^-1 . While direct comparative data for PPID is not provided in the search results, the enzyme kinetics of PPIases generally follow Michaelis-Menten kinetics.

PPID's substrate specificity partly overlaps with other cyclophilins but also shows unique preferences. For example, while CYPJ has been shown to catalyze isomerization in peptides containing norleucine-proline, isoleucine-proline, and glutamine-proline bonds , PPID may have different substrate preferences based on its specific structural features. This differential substrate specificity is significant for researchers designing targeted experiments or developing specific inhibitors.

What are the recommended protocols for measuring PPID enzymatic activity?

The standard method for measuring PPID enzymatic activity is the PPIase assay, similar to those used for other cyclophilins. The assay typically involves:

• Substrate preparation: Using synthetic peptide substrates containing proline residues, often with chromogenic or fluorogenic groups for detection.

• Enzyme preparation: Diluting purified PPID to appropriate concentrations in assay buffer.

• Reaction monitoring: Following the cis-to-trans isomerization spectrophotometrically, often using the coupling with chymotrypsin, which preferentially cleaves after trans-proline.

For kinetic analysis, researchers should vary substrate concentrations to determine Michaelis-Menten parameters. When evaluating inhibitors like cyclosporin A, dose-response curves should be generated to determine IC50 values, similar to the approach used for CYPJ where an IC50 of 12.1±0.9 μM was determined for cyclosporin A inhibition .

How can researchers design experiments to study PPID's role in cancer cell apoptosis?

Given that PPID overexpression is known to suppress apoptosis in cancer cells , researchers can design experiments to investigate this relationship using the following approaches:

• Gene expression modulation: Using siRNA knockdown or CRISPR-Cas9 genome editing to reduce PPID expression in cancer cell lines, followed by apoptosis assays.

• Overexpression studies: Transfecting cancer cells with PPID expression vectors to assess effects on apoptotic pathways.

• Inhibitor studies: Treating cells with cyclosporin A or other PPID inhibitors to assess changes in apoptotic susceptibility.

• Protein interaction studies: Using co-immunoprecipitation or yeast two-hybrid systems to identify PPID-interacting proteins involved in apoptotic pathways.

Apoptosis can be measured using various techniques including Annexin V/PI staining and flow cytometry, TUNEL assays, or caspase activity assays. Researchers should include appropriate controls and consider cell type-specific effects when interpreting results.

What quasi-experimental designs are appropriate for studying PPID functions in vivo?

When studying PPID functions in vivo, quasi-experimental designs can be valuable when true experimental approaches are not feasible. Quasi-experiments share similarities with randomized controlled trials but lack random assignment to treatment or control groups . For PPID research, appropriate quasi-experimental designs might include:

• Time series analysis: Measuring PPID expression or activity over time in response to treatments or developmental stages.

• Non-equivalent control group designs: Comparing naturally occurring high and low PPID-expressing tissues or organisms.

• Regression discontinuity designs: Useful when there's a cutoff point in PPID expression that determines group assignment.

When implementing these designs, researchers must carefully account for potential confounding variables that could affect internal validity . Statistical techniques such as propensity score matching or difference-in-differences analysis can help address baseline differences between groups.

How should researchers interpret contradictory results in PPID functional studies?

When encountering contradictory results in PPID functional studies, researchers should consider:

• Experimental context differences: Cell type, tissue type, or organism differences can significantly impact PPID function. Different cell lines may express varying levels of PPID interacting partners.

• Methodological variations: Differences in assay conditions, protein tagging strategies, or purification methods can affect results.

• Isoform-specific effects: Potential existence of splice variants or post-translationally modified forms of PPID.

• Indirect vs. direct effects: Determining whether observed effects are directly attributable to PPID or mediated through interaction partners.

To resolve contradictions, researchers should conduct carefully controlled comparative studies using standardized protocols across different experimental systems. Meta-analysis of published data can also help identify patterns and sources of variability.

What statistical approaches are recommended for analyzing PPID enzymatic kinetics data?

For analyzing PPID enzymatic kinetics data, researchers should consider:

• Non-linear regression analysis: For fitting data to Michaelis-Menten or other appropriate kinetic models.

• Lineweaver-Burk or Eadie-Hofstee transformations: To visualize and analyze enzyme kinetics data, though direct non-linear fitting is generally preferred for parameter estimation.

• Global fitting approaches: When analyzing inhibition data to determine inhibition mechanisms and constants.

• Bootstrap or jackknife resampling: To estimate confidence intervals for kinetic parameters.

When comparing PPID with other cyclophilins like CYPJ (which has a kcat/KM of 9.5×10^4 s^-1 M^-1 ), researchers should ensure statistical comparisons account for experimental conditions and use appropriate statistical tests (t-tests, ANOVA) with corrections for multiple comparisons when necessary.

How can researchers determine if observed effects are specific to PPID versus other cyclophilins?

Determining PPID-specific effects versus those that might be shared with other cyclophilins requires:

• Comparative studies: Direct side-by-side comparison of PPID with other cyclophilins (e.g., CYPA, CYPJ) using identical experimental conditions.

• Selective inhibition: Using PPID-specific inhibitors, if available, or comparing effects of pan-cyclophilin inhibitors with more selective compounds.

• Domain swapping experiments: Creating chimeric proteins by swapping domains between PPID and other cyclophilins to identify regions responsible for specific functions.

• Substrate specificity profiling: Comparing the ability of PPID and other cyclophilins to process various peptide substrates, similar to the analysis done for CYPJ .

• Gene editing approaches: Using CRISPR-Cas9 to specifically knockout PPID while leaving other cyclophilins intact, followed by rescue experiments with various cyclophilins.

These approaches help delineate the unique roles of PPID from the functions it shares with other cyclophilin family members.

What are the most promising future research directions for PPID studies?

Future research on PPID should focus on:

• Structure-function relationships: Detailed structural studies using X-ray crystallography or cryo-EM to understand how PPID's three TPR repeats contribute to substrate specificity and protein interactions.

• Cancer biology applications: Further investigation of PPID's role in suppressing apoptosis in cancer cells , potentially leading to therapeutic applications.

• Transcriptional regulation mechanisms: Elucidating the specific mechanisms by which PPID influences gene transcription, similar to studies on other PPIases that have revealed roles in RNA polymerase II regulation .

• Development of specific inhibitors: Creating PPID-selective inhibitors as research tools and potential therapeutic agents, building upon knowledge of cyclosporin A inhibition mechanisms .

• Systems biology approaches: Integrating PPID into broader signaling networks to understand its context-dependent functions in different cellular environments.